InVivo Therapeutics is a research and clinical-stage biomaterials and biotechnology company focused on developing and commercializing biopolymer scaffolding devices for the treatment of spinal cord injuries. The Company is developing Neuro-Spinal Scaffold implant, an investigational bioresorbable polymer scaffold for acute SCI, and Therapeutic Trails injection program for the treatment of chronic SCI.

Employee Rating

2.8More
TypePublic
HQCambridge, US
Founded2005
Size (employees)37 (est)
Websiteinvivotherapeutics.com
InVivo Therapeutics was founded in 2005 and is headquartered in Cambridge, US
Report incorrect company information

Viewing summary data as a guest

Sign up for free to see all data

Key People/Management at InVivo Therapeutics

Christopher McNulty

Christopher McNulty

CFO
Kenneth DiPietro

Kenneth DiPietro

Board Director
Pamela Stahl

Pamela Stahl

Chief Commercial Officer
Tamara Joseph

Tamara Joseph

Senior Vice President, General Counsel/Chief Compliance Officer
William DAgostino

William DAgostino

Senior Vice President, Operations
Ann Merrifield

Ann Merrifield

Chair of the Board
Show more

InVivo Therapeutics Office Locations

InVivo Therapeutics has an office in Cambridge
Cambridge, (HQ)
One Kendall Square, Building 1400 East, Floor 4
Show all (1)
Report incorrect company information

InVivo Therapeutics Financials and Metrics

InVivo Therapeutics Revenue

USD

Net income (Q3, 2018)

(3.2m)

EBIT (Q3, 2018)

(2.1m)

Market capitalization (4-Dec-2018)

18.3m

Closing stock price (4-Dec-2018)

2.0

Cash (30-Sep-2018)

19.7m
InVivo Therapeutics's current market capitalization is $18.3 m.
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

General and administrative expense

8.5m7.6m12.3m11.5m13.5m

R&D expense

10.5m10.3m10.1m12.6m11.1m

Operating expense total

19.0m17.8m22.4m24.1m24.6m

EBIT

(19.0m)(17.8m)(22.4m)(24.1m)(24.6m)
Quarterly
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018

General and administrative expense

2.4m1.8m1.7m1.8m3.2m3.2m3.4m3.0m3.0m2.6m3.3m3.7m3.4m3.4m1.8m1.2m

R&D expense

3.0m3.2m3.1m2.4m2.3m2.5m2.4m2.6m2.8m3.3m3.4m3.2m2.9m1.4m1.0m928.0k

Operating expense total

5.4m5.1m4.7m4.2m5.5m5.8m5.9m5.6m5.8m5.9m6.7m6.9m6.3m4.8m2.8m2.1m

EBIT

(5.4m)(5.1m)(4.7m)(4.2m)(5.5m)(5.8m)(5.9m)(5.6m)(5.8m)(5.9m)(6.7m)(6.9m)(6.3m)(4.8m)(2.8m)(2.1m)
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Cash

14.0m13.5m20.2m21.5m12.9m

Prepaid Expenses

1.1m184.0k451.0k

Inventories

20.1k

Current Assets

14.6m15.0m20.7m33.9m13.8m
Quarterly
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018

Cash

18.3m9.8m20.9m17.6m24.5m25.1m22.1m45.8m41.6m37.7m14.4m14.3m16.4m11.6m22.3m19.7m

Prepaid Expenses

445.0k378.0k342.0k543.0k397.0k268.0k617.0k682.0k413.0k940.0k657.0k475.0k

Current Assets

19.1m10.7m21.6m18.3m25.4m25.9m22.8m46.7m42.7m38.4m27.4m22.9m18.0m13.1m23.6m20.3m

PP&E

2.2m2.0m1.8m1.4m1.3m1.1m846.0k736.0k630.0k395.0k305.0k190.0k
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Net Income

(38.8m)(18.3m)(33.3m)(23.4m)(26.7m)

Depreciation and Amortization

740.7k752.0k689.0k553.0k395.0k

Accounts Payable

(253.3k)(330.0k)(48.0k)489.0k(23.0k)

Cash From Operating Activities

(14.9m)(15.3m)(16.3m)(16.7m)(19.7m)
USDY, 2018

Financial Leverage

1.2 x
Show all financial metrics

InVivo Therapeutics Operating Metrics

FY, 2016

Facilities

1

Patents (Foreign)

8

Patents (US)

8

Patents Pending

12
Show all operating metrics
Report incorrect company information

InVivo Therapeutics Online and Social Media Presence

Embed Graph
Report incorrect company information

InVivo Therapeutics Company Life and Culture

Report incorrect company information

InVivo Therapeutics Frequently Asked Questions

  • When was InVivo Therapeutics founded?

    InVivo Therapeutics was founded in 2005.

  • Who are InVivo Therapeutics key executives?

    InVivo Therapeutics's key executives are Christopher McNulty, Kenneth DiPietro and Pamela Stahl.

  • How many employees does InVivo Therapeutics have?

    InVivo Therapeutics has 37 employees.

  • Who are InVivo Therapeutics competitors?

    Competitors of InVivo Therapeutics include NeuralStem, Brainstorm Cell Therapeutics and Semma Therapeutics.

  • Where is InVivo Therapeutics headquarters?

    InVivo Therapeutics headquarters is located at One Kendall Square, Building 1400 East, Floor 4, Cambridge.

  • Where are InVivo Therapeutics offices?

    InVivo Therapeutics has an office in Cambridge.

  • How many offices does InVivo Therapeutics have?

    InVivo Therapeutics has 1 office.